Back to search
FDAFDA · Food and drugs·Recall number D-0179-2023

Epinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only, Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901. Product Code EP130

Published February 1, 2023 · Recall initiated: December 19, 2022

Summary

FDA records drug Class I recall D-0179-2023, published February 1, 2023 and initiated December 19, 2022. Recalling firm: Spectrum Laboratory Products, Inc.; Status: Terminated; Reported quantity: 1 bottle; Lot: Lot # 1KG0865 EXP 31-Mar-2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Spectrum Laboratory Products, Inc.
Distributor
Nationwide in the USA, Puerto Rico and Canada
Lot
Lot # 1KG0865 EXP 31-Mar-2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Epinephrine (L-Adrenaline), USP, CAS 51-43-4, 1 KG amber glass bottle in a vacuum sealed pouch, Rx only, Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901. Product Code EP130 recalled?

Yes. FDA published recall D-0179-2023 on February 1, 2023. Reported hazard: Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product

What should I do if I have this product?

Voluntary: Firm initiated · Letter